Evidera has reached an exclusive collaboration agreement with Shin Nippon Biomedical Laboratories’ (SNBL) subsidiary Clinical Study Support (CSS) to jointly deliver more consulting and analytical capabilities for clinical research.
Evidera has entered into an exclusive collaboration agreement with Clinical Study Support, Inc. (CSS), a subsidiary of Shin Nippon Biomedical Laboratories Ltd. (SNBL). This agreement extends both organizations’ capabilities to deliver more robust consulting and analytical capabilities and creates a more complete geographic customer solution for clinical, real-world and patient-centered research.